Drugs / mRNA-1273.712
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06634797 | Oct 2024 → Jan 2025 | — | ModernaTX, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-1273.712 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06634797 ↗ |
| Modality | Messenger RNA (mRNA) | “mRNA-1273.712 Vaccine” NCT06634797 ↗ |
| Route | Intramuscular | “Intramuscular (IM) injection.” NCT06634797 ↗ |